Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03096197 · ClinicalTrials.gov registry record · NA

Exoskeleton and Spinal Cord Stimulation for SCI

A NA study of Spinal Cord Injury and Muscle Spasticity, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03096197 is a NA study of Spinal Cord Injury and Muscle Spasticity that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 24 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03096197, a NA study of Spinal Cord Injury and Muscle Spasticity, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The overall aim of this project is to assess the effect of combining transcutaneous lumbosacral stimulation (TLS) during Exoskeleton Assisted Walking (EAW) compared to EAW alone without stimulation on walking recovery.

Interventions

  • DEVICE Exoskeleton-Assisted Walking
  • DEVICE Transcutaneous Lumbosacral Stimulation (TLS)

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2017-03-30
Est. Completion 2029-09
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT03096197

The ClinicalTrials.gov registry entry for NCT03096197 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (72% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Exoskeleton-Assisted Walking is the first listed.

NCT03096197 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03096197 about?

NCT03096197 is a clinical study titled "Exoskeleton and Spinal Cord Stimulation for SCI". The overall aim of this project is to assess the effect of combining transcutaneous lumbosacral stimulation (TLS) during Exoskeleton Assisted Walking (EAW) compared to EAW alone without stimulation on walking recovery.

What is the current status of trial NCT03096197?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2017-03-30. Estimated completion is 2029-09.

What conditions does trial NCT03096197 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Muscle Spasticity, Ambulation Difficulty.

What interventions are being tested in trial NCT03096197?

The interventions under investigation include: Exoskeleton-Assisted Walking (DEVICE), Transcutaneous Lumbosacral Stimulation (TLS) (DEVICE).

Who is sponsoring clinical trial NCT03096197?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03096197 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.